Views
Cancer epidemic hits Europe: 1 million cases lost during Covid_19:
Even before Covid-19 hit Earth, cancer was the leading cause of death worldwide, and a new study indicates that weight will increase significantly. Researchers predict that the pandemic's disastrous effects on early diagnosis and treatment are likely to push Cancer outcomes in Europe by nearly a decade.
The European Groundshot commission on Cancer Research gathered comprehensive new data on cancer research activity across Europe over the past 12 years for a study that was published in the Lancet Oncology.It revealed that over the past two years, an estimated one million cancer cases were missed across Europe.
Related Topics:
The report refocuses on cancer research and the European government's efforts to provide cancer care that is more affordable, of higher quality, and more equitable.The group of specialists dissected information on the effect of the Coronavirus pandemic across Europe and found that clinicians saw 1.5 million less patients with disease in the primary year of the pandemic, with one of every two patients with malignant growth not getting a medical procedure or chemotherapy on time.
"To locate these missing cancers, we are currently in a race against time.The first pandemic wave also had a chilling effect on cancer research, with labs closing and clinical trials being postponed or canceled.The lead author of the paper, Professor Mark Lawler, stated, "We are concerned that Europe is heading toward a cancer epidemic in the next decade if cancer health systems and Cancer research are not urgently prioritized."
The study estimates that up to one million European citizens may have undiagnosed cancer as a result of the cancer backlog, which resulted in 100 million missed cancer screening tests.
Cancer Research in Europe - 12 Recommendations:
"Cancer research in the post-Brexit UK is at a crossroads where strategic decisions will determine whether we continue to thrive and collaborate internationally or whether isolationism will reduce our global standing." Richard Sullivan, professor of cancer and global health at King's College London, added.
The paper's findings highlight the growing gap between the rest of Europe and cancer research activities, capabilities and outcomes. As a result, the newspaper urges the government to focus on central and eastern Europe. In a call to action to rethink Cancer research and its application in Europe, they made twelve key recommendations.
“To achieve our ambitious 70 goals, we have an unprecedented opportunity to rethink Cancer research and its application:35 Vision, cancer patients in Europe will have an average 10-year survival rate of 70% by 2035 Let's seize this opportunity," Professor Lawler continued.
Post a Comment